Smith & Nephew plc files as a foreign private issuer whose SEC reports document a global medical technology business and its NYSE-traded American depositary receipts. Form 6-K reports cover trading updates, product and strategy communications, annual meeting results, dividend approvals, voting rights and capital, share buyback programs, and ordinary-share matters underlying the ADR program.
The filing record also includes disclosures on board elections, remuneration votes, treasury shares, share-plan awards under the RISE Share Plan, PDMR transactions, forward-looking statements, and business-unit performance across Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. These filings link the company’s UK corporate governance and capital structure to its U.S. reporting obligations under Form 20-F foreign-issuer status.